Navigation Links
Familial Susceptibility to Mercury is a Risk Factor for Autism
Date:8/9/2011

ATLANTA, Aug. 9, 2011 /PRNewswire-USNewswire/ -- Researchers from Australia have identified an ancestry of Pink Disease (Infantile Acrodynia) as a risk factor for Autism Spectrum Disorders.  Pink disease was common in the first half of the 20th century as a mysterious illness affecting children between the ages of eighteen months and three and a half years.  The disorder presented with apathy, irritability, and progressive loss of speech, symptoms very similar to those exhibited by children with autism. Nearly fifty years passed before a connection was made between the disease and exposure to mercury in teething powder, worm medications and diaper rinses.  The disease developed in approximately 1 in 500 children exposed to the products and experts identified idiosyncratic sensitivity to mercury as the key risk factor.

(Photo: http://photos.prnewswire.com/prnh/20110809/DC49865)

The new study, published July 28th in the Journal of Toxicology and Environmental Health available at http://www.tandfonline.com/doi/abs/10.1080/15287394.2011.590097?journalCode=uteh20, investigated the hypothesis that autism can result from the interaction between mercury exposure and a genetic predisposition to sensitivity to mercury. Currently, 43 peer-reviewed studies support a link between mercury and autism, and experts agree that autism is caused by the interaction of genetic susceptibility and environmental exposures.

The Australian researchers, David Austin, Ph.D. and Kerrie Shandley investigated whether individuals with a known hypersensitivity to mercury were more likely to have descendants with an autism spectrum disorder. They surveyed 522 adult survivors of Pink Disease about the health of their grandchildren.  They found that 1 in 25 of these grandchildren had an autism spectrum disorder compared to 1 in 160 children of the same ages in the general population in Australia, a staggering six-fold increase in relative risk.  Dr. Austin had the following comment, "The large elevation in autism prevalence in this group of children was startling especially given that rates of other childhood disorders were at expected levels. The thing that differentiates these children from the general population, to which they were compared, is a family history of mercury sensitivity. We were simply blown away by the results."

SafeMinds Board member Lyn Redwood RN, MSN whose son was diagnosed with mercury toxicity and autism calls on the pharmaceutical industry to once and for all remove mercury from their products, "The FDA has identified over 130 medical products that contain mercury http://www.safeminds.org/news/documents/Mercury%20in%20Drug%20and%20Biologic%20Products.pdf and 7 vaccines that contain mercury http://www.vaccinesafety.edu/thi-table.htm. The continued use of these products in to the 21st century when safer and more effective alternatives exist is unacceptable and dangerous."  

For more information on the symptoms of Pink Disease and the overlap with autism please visit http://www.safeminds.org/news/documents/Acrodynia%20comparison%20combined.pdf or contact Lyn@safeminds.org.


'/>"/>
SOURCE SafeMinds
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
2. Colesevelam HCl Lowered LDL Cholesterol in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
3. FDA Clears Three Additional Antimicrobials for Use on TREK Sensititre(R) In Vitro Diagnostic (IVD) MIC Susceptibility Plates: Minocycline and Telavancin Used to Treat MRSA and Other Infections; and Tigecycline, Now Cleared for Streptococcus Pneumoni
4. Global Mercury Treaty May Include Ban on Mercury in Medicine
5. Medivance Named to Mercury 100 Ranking of the 100 Fastest-Growing Private Companies in the Boulder Valley
6. Florida Legislature Refuses to Limit Mercury in Vaccines
7. United Nations Urged to Ban Mercury in Vaccines
8. LaVoie Group Wins Gold Mercury Award For Medical Device Company, Alphatec Spine
9. LaVoie Group Wins Two Mercury Excellence Awards
10. Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930
11. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):